CONTACT POLPHARMA GROUP POLPHARMA B2B

Similar documents
AVAILABLE DOSSIERS. Product name Pharmaceutical form Strength Reference Therapeutic class

DOSSIER LIST. tlo_seledyn.pdf :38:01 CMY K CM MY CY

DOSSIER LIST. tlo_seledyn.pdf :38:01 CMY K CM MY CY

CENTRAL NERVOUS SYSTEM CARDIOVASCULAR SYSTEM DIGESTIVE SYSTEM BONE DISEASE UROLOGICS ANTIBACTERIAL ANTIVIRALS ANTIMYCOTICS ANTIDEPRESSIVES

formulations Product List- row

Table 1 Details of products supplied and the correlation coefficient of each of these products against its reference.

Innovative Products Available. OTC Products Available

Table updated 15 th February Sodium valporate 15 th February Ramipril & Felodipine 15 th February 2019

J Jubilant Pharma Group, catering to Dosage

Therapeutic options for adult patients unable to take solid oral dosage forms (Adapted from UKMi Q&A for use in Northern Ireland) Sep 2015

ASEBP and ARTA TARP Drugs and Reference Price by Categories

SOLID DOSAGE FORMULATIONS

DT Description Price Category Price change Percentage BNF 1.2 Mebeverine 135mg tablets (100) 759 M %

PORTFOLIO Q October 2015 Availability of products is subject to patent restrictions in countries where applicable patents are in effect 1/6

Drugs Categories. 4. Which suffix do erectile dysfunction generic drug names often end with?

COMMERCIAL APIs. S. No Molecule Name Therapeutic Category USDMF EDMF CEP IH

Table updated 26 th February Salbutamol 26 th February Lofepramine hydrochloride 22 nd February Zoledronic acid 21 st February 2019

While there is around a 3% increase shown in costs for Category M lines, I think this is due to the inclusion of more lines in Category M.

PORTFOLIO Q June 2014 Availability of products is subject to patent restrictions in countries where applicable patents are in effect 1/5

Upper Peninsula Health Plan Advantage (HMO) (List of Covered Drugs)

Table A1: Fifty Most Often Repeated Oral Drug Product Shortages (35 ingredients), Canada,

PRODUCT LIST June 2018

DT Description Price Category Price change

PULMONARY ARTERIAL HYPERTENSION AGENTS

TRICARE Uniform Formulary. Pre-Authorization Requirements

2018 Step Therapy Criteria

PORTFOLIO MADE WITH CARE. FDF Generics Chlorhexidine API

Table 1: Price increases for Brand Name Drugs with Generic Equivalents

Prescription Drugs. Medicare & Medicaid Briefings National Health Policy Forum February 22, Jim Hahn Congressional Research Service

Pharmacy Costs: Can I Make a Difference?

PBS Growth. The changing composition of the PBS. PBS Top 10 drugs in transition. Shifting sands for industry as generic volume soars

DT Description Price Category Price change Percentage BNF 1.2 Mebeverine 135mg tablets (100) 702 M %

ANTI COLD / ANTI ALLERGIC / ANTI-ASTHMATICS GIT PRODUCTS

Anti Diabetic. BE Reference product. Diamicron Gliclazide MR Tablets 60 mg (Servier, France) HCl XR Tablets 500 mg (BMS, US)

A BULLETIN FOR PHARMACY SERVICE PROVIDERS FROM ALBERTA BLUE CROSS. Pan-Canadian Select Molecule Price Initiative for Generic Drugs

2018 PDP Premier Step Therapy Document September 2018 Y0114_18_33144_I_009

DT Description Price Category Price change Percentage

LIST OF DRUGS DURING 2004

Pharmacy Management Drug Policy

National Horizon Scanning Centre. Tadalafil for pulmonary arterial hypertension. October 2007

Product Name Strength Dosage Form Therapeutic Area Dossier Status. Aceclofenac 100mg Film coated Tablets Analgesia-inflammation Approved

MEDICINES CONTROL COUNCIL

GOVERNMENT GAZETTE OF THE REPUBLIC OF NAMIBIA. N$4.00 WINDHOEK - 26 July 2011 No. 4761

Supplementary Appendix

2017 UnitedHealthcare Services, Inc.

TLS HEALTH Product list up-dated 2017 (Origin: Portugal)

TENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes. 28 February 2014

CRITERIA Trial of two generic formulary products from the following: atomoxetine or ADHD stimulant medication.

Cardiovascular Risk Reduction in Diabetic Mellitus. Presenter: Dr. Martin N. Wanyoike MB.CHB., M. Med.(internal med) Physician / Cardiologist

US pharmaceutical market: trends, issues, forecast. Doug Long Vice President Industry Relations IMS Health

Our Values. Quality Intelligent efforts in everyday practice. Innovation Change that unlocks new value. Performance Passion for results

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Health Technology Appraisal. Drugs for the treatment of pulmonary arterial hypertension

QTY LIMIT COPAY (30 DAY/90 DAY) BENIGN PROSTATIC HYPERPLASIA FINASTERIDE $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 $4/$8

Step Therapy Requirements

Amitriptyline Hydrochloride Heart Health & BP Amlodipine Besylate 5mg Norvasc Antibiotics Amoxicillin 500 mg Amoxil

Cardiovascular Subcommittee of PTAC Meeting held 17 February 2016

Chapter 2 ~ Cardiovascular system

Amitriptyline Hydrochloride Heart Health & BP Amlodipine Besylate 5mg Norvasc Antibiotics Amoxicillin 500 mg Amoxil

PHARMA LIMITED (NIGERIA)

ACEBUTOLOL HCL 100MG TABLET GENERIC BETA BLOCKERS ALISKIREN 150MG TABLET RASILAZ RENIN INHIBITOR

Drug Regimen Optimization

MEDICINES CONTROL COUNCIL

P R O D U C T L I S T S E P T E M B E R

ANNOUNCEMENT. Dear Valued Customer:

National Medicines Management Programme

Pharma X Consultancy Inc. Inventory List

Kern Pharma Portfolio 2014

CATEGORIES: QUIZ 2. Drugs Categories. 1. What drug subcategory often ends with the suffix -asone?

Information for Vermont Prescribers of Prescription Drugs

SASKATCHEWAN FORMULARY COMMITTEE UPDATE BULLETIN TO THE 55th EDITION OF THE SASKATCHEWAN FORMULARY

Volume 6; Number 1 January 2012 NICE CLINICAL GUIDELINE 127: HYPERTENSION CLINICAL MANAGEMENT OF PRIMARY HYPERTENSION IN ADULTS (AUGUST 2011)

Medicinal products of Kusum Pharm Ltd. registered in Ukraine - 1 -

National Horizon Scanning Centre. Oral and inhaled treprostinil for pulmonary arterial hypertension: NYHA class III. April 2008

Merrill Lynch Pharmaceutical, Biotechnology & Medical Device Conference New York, February 4, 2004

Industry Relationships and Institutional Affiliations

WORK PLAN FOR THE EFFICACY WORKING PARTY (EWP) CHAIRPERSON: Barbara van Zwieten-Boot

Information for Vermont Prescribers of Prescription Drugs

ADVANCED THERAPIES FOR PHARMACOLOGICAL TREATMENT OF PULMONARY HYPERTENSION

MEDICINES CONTROL COUNCIL

Leitner Christian. Best Selling Drugs

SOLID DOSAGE FORMULATIONS

Hypertension, Hyperlipidemia and Obesity. Mi-CCSI

Alaska Medicaid 90 Day** Generic Prescription Medication List

Updates to the Alberta Drug Benefit List. Effective September 1, 2018

Drug Classifications

Have you been paying for your prescription drugs? Stop!

Orodispersible tablets & Tablets

Allopathic Products:

Medicines Procurement South West

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 28 May 2008

Nclex para la Enfermera Hispana

Pulmonary Arterial Hypertension Drug Prior Authorization Protocol

Therapeutic Categories Outlook

Daiichi Sankyo, Inc. (DSI)

MEDICINES CONTROL COUNCIL

Oral Therapies for Pulmonary Arterial Hypertension

Chapter / Section / Drug

Transcription:

DOSSIER FDFLIST

Product name Pharmaceutical form Strength Reference Therapeutic class ALIMENTARY TRACT & METABOLISM 1. Esomeprazole sodium or injection 40 mg Nexium / AstraZeneca Antiulcerant 2. Omeprazole sodium 40 mg Losec / AstraZeneca Antiulcerant 3. Orlistat Capsules 60 mg 120 mg Alli / GSK Xenical / Roche Obesity treatment 4. Pantoprazole sodium sesquihydrate for injection 40 mg Pantozol / Altana Antiulcerant 5. Sitagliptin phosphate 25 mg 50 mg 100 mg Januvia / Merck Oral antidiabetic ANTI-INFECTIVES FOR SYSTEMIC USE 6. Aciclovir Tablets 200 mg 400 mg 800 mg Zovirax / Glaxo Antiviral for systemic use 7. Clarithromycin 500 mg Klacid IV / Abbot Antibacterial for systemic use 8. Levofloxacin hemihydrate 250 mg 500 mg Tavanic / Aventis Antibacterial for systemic use 9. Levofloxacin hemihydrate Solution 5 mg/ml (50 ml, 100 ml) Tavanic / Aventis Antibacterial for systemic use 10. Linezolid 600 mg Zyvox / Pfizer Antibacterial for systemic use 11. Linezolid Solution 2 mg/ml (300 ml) Zyvox / Pfizer Antibacterial for systemic use 12. Tenofovir 245 mg Viread / Gilead Science Antiviral for systemic use 13. Voriconazole 50 mg 200 mg Vfend / Pfizer Antifungal for systemic use 14. Voriconazole 200 mg Vfend / Pfizer Antifungal for systemic use ANTINEOPLASTIC & IMMUNOMODULATING AGENTS 15. Imatinib 100 mg 200 mg 400 mg Glivec / Novartis Antineoplastic

AVAILABLE DOSSIERS Product name Pharmaceutical form Strength Reference Therapeutic class CARDIOVASCULAR SYSTEM 16. Amlodipine besilate + Atorvastatin calcium 5mg + 10mg 10mg + 10mg 10mg + 20mg 5mg + 20mg Caduet / Pfizer Calcium-channel blocker and cholesterol & triglyceride regulator combination 17. Amlodipine besilate + Ramipril Capsules 5mg + 5mg 5mg + 10mg 10mg + 5mg 10mg + 10mg --- Calcium-channel blocker & ACE inhibitor combination 18. Amlodipine maleate + Valsartan 5 mg + 80 mg 5 mg + 160 mg 10 mg + 160 mg Exforge / Novartis Calcium-channel blocker & angiotensin-ii antagonist combination 19. Bosentan * 62.5 mg 125 mg Tracleer / Actelion Pulmonary arterial hypertension (PAH) treatment 20. Hydrochlorothiazide * Tablets 12.5 mg 25 mg --- Diuretic 21. Indapamide Prolonged-release tablets 1.5 mg Natrilix / Servier Diuretic 22. Metoprolol succinate Prolonged-release tablets 23.75 mg 47.5 mg 95 mg 190 mg Beloc-Zoc / AstraZeneca Beta blocking agent 23. Metoprolol tartrate Solution for injection 1 mg/ml Betaloc / AstraZeneca Beta blocking agent 24. Noradrenaline bitartrate Solution for injection 1 mg/ml (1 ml, 4 ml) Noradrenaline / Hospira Vasopressor and cardiac arrest management 25. Rosuvastatin calcium * 5 mg 10 mg 20 mg 40 mg Crestor / AstraZeneca Cholesterol & triglyceride regulator 26. Sildenafil citrate * 20 mg Revatio / Pfizer Pulmonary arterial hypertension (PAH) treatment 27. Simvastatin 10 mg 20 mg 40 mg 80 mg Zocor / MSD Cholesterol & triglyceride regulator DERMATOLOGICALS 28. Dimetindene Gel 1 mg/g Fenistil / Novartis Topical antipruritic GENITO-URINARY SYSTEM & SEX HORMONES 29. Tadalafil * 2.5 mg 5 mg 10 mg 20 mg Cialis / Eli Lilly Erectile dysfunction treatment 30. Vardenafil hydrochloride * 5 mg 10 mg 20 mg Levitra / Bayer Erectile dysfunction treatment MUSCULO-SKELETAL SYSTEM 31. Alendronic acid * Tablets 70 mg Fosamax / Merck Bone calcium regulator

February 2017 Product name Pharmaceutical form Strength Reference Therapeutic class NERVOUS SYSTEM 32. Atomoxetine Capsules 5mg 10mg 18mg 25mg 40mg 60mg 80mg 100mg Strattera / Eli Lilly ADHD treatment 33. Citalopram hydrobromide 10 mg 20 mg 30 mg 40 mg Seropram / Lundbeck Antidepressant 34. Haloperidol Solution for injection 5 mg/ml (1 ml) Haldol / Janssen Antipsychotic 35. Memantine hydrochloride 10 mg 20 mg Ebixa / Lundbeck Alzheimer disease treatment 36. Pregabalin Capsules 25 mg 50 mg 75 mg 100 mg 150 mg 200 mg 225 mg 300 mg Lyrica / Pfizer Antiepileptic 37. Propofol Emulsion for injection or infusion 10 mg/ml (20 ml) Diprivan / Astra Zeneca Anaesthetic 38. Quetiapine fumarate 25 mg 100 mg 150 mg 200 mg 300 mg Seroquel / AstraZeneca Antipsychotic OPHTHALMOLOGICALS 39. Bimatoprost 40. Brimonidine NEW! 41. Dorzolamide 42. Dorzolamide + Timolol 0.3 mg/ml Lumigan / Allergan Miotic & antiglaucoma 2 mg/ml Alphagan / Allergan Miotic & antiglaucoma 20 mg/ml Trusopt / MSD Miotic & antiglaucoma (20 mg + 5 mg)/ml Cosopt / MSD Miotic & antiglaucoma RESPIRATORY SYSTEM 43. Montelukast sodium 10 mg Singulair / Merck Asthma treatment 44. Montelukast sodium NEW! Oral granules (sachets) 4 mg Singulair / Merck Asthma treatment 45. Xylometazoline hydrochloride + Dexpanthenol NEW! Nasal spray solution (1 mg + 50 mg)/ml Nasic / Cassella-med Nasal descongestant & mucosal regenerator * Polpharma Group API For more information and up-dates regarding available dossiers and dossiers in development, please contact your assigned Sales Manager or our Commercial Department. Note: Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement. Availability may be restricted to certain markets or countries.

WE OFFER HIGH LEVEL OF CUSTOMER SERVICE EXCELLENT PRODUCTS WITH CTD DOSSIERS MEETING EU REQUIREMENTS REGULATORY KNOWLEDGE AND EXPERTISE FULL SUPPORT IN DEVELOPING REGISTRATION STRATEGIES TO MEET THE NEEDS OF OUR CUSTOMERS EXECUTION AND SUPPORT IN REGISTRATION PROCEDURES UPON CUSTOMER S REQUEST QA SERVICE AND PHARMACOVIGILANCE SERVICE (PSUR) INTELLECTUAL PROPERTY EXPERTISE HIGHLY SKILLED AND PROFESSIONAL TEAM OF PROJECT MANAGERS PARTNERSHIP IN A WIN-WIN STRATEGY CONTACT POLPHARMA GROUP Pharmaceutical Works Pelplińska 19 83-200 Starogard Gdański Poland Phone: +48 58 563 16 00 Fax: +48 58 562 23 53 www.polpharma.pl POLPHARMA B2B STRATEGIC PARTNER, FARMAPROJECTS Santa Eulàlia 240-242 08902 L Hospitalet de Llobregat Barcelona (Spain) Phone: +34 93 508 05 00 Fax. +34 93 508 05 01 e-mail: salesb2b@polpharma.com www.polpharmab2b.com